德国拜耳利伐沙班可用来治疗什么病症

It is a new type of oral anticoagulant drug that was approved for marketing in the EU in September 2008. It is the first Factor Xa inhibitor developed and launched by Bayer Pharmaceuticals after 10 years of research and development. It is mainly used to treat venous thrombosis in adults. It can also prevent venous thrombosis in adult patients undergoing elective hip or knee replacement surgery, and can be used in patients with non-valvular atrial fibrillation to reduce the risk of stroke and systemic embolism.

The German company Bayer is committed to helping people overcome the major challenges brought about by the growing and aging global population through products and services and benefit mankind. Polymers, medicine and health care, chemical industry and agriculture are the company's four pillar industries. Rivaroxaban is a highly bioavailable coagulation factor inhibitor produced by Bayer.

Rivaroxaban is used to prevent venous thrombosis (VTE) in adult patients undergoing elective hip or knee replacement surgery. The recommended dose is 10 mg, taken orally, once daily. Treatment time is 35 days for hip replacement patients and 12 days for knee replacement patients. If you miss a dose, you need to take it in time, whether you take it with food or not. Patients need to follow their doctor's instructions carefully during treatment.

In clinical trials, rivaroxaban could significantly reduce the incidence of total VTE, major VTE, and symptomatic VTE compared with enoxaparin, while the incidence of major bleeding events and other bleeding events was similar in the two groups. RECORD3~4 studies compared the safety and effectiveness of rivaroxaban and enoxaparin in preventing venous thromboembolism in patients after elective total knee replacement. The results showed that the efficacy of rivaroxaban group was not inferior to traditional treatment, and the risk of bleeding was equivalent to or lower than traditional treatment. 

The above is an introduction to the treatment symptoms and other related content of Bayer in Germany. I hope it will be helpful to you.

Recommended related hot articles: /newsDetail/90040.html